Key Takeaways:
- ALEBUND-B (09637.HK) opened at $42, up 85.8% from its IPO price of $22.6.
- The stock closed at $42.52 on the gray market, implying strong pre-debut demand.
- About 6.59 million shares changed hands at the market open.
Back
ALEBUND-B opens 85.8% higher at $42 on Hong Kong debut
ALEBUND-B (09637.HK) opened at $42 on its Hong Kong debut, surging 85.8 percent from the listing price of $22.6.
The stock had closed at $42.52 on the gray market a day earlier, up 88.1 percent from the IPO price, signaling strong pre-debut demand. About 6.59 million shares changed hands at the opening bell on the Main Board.
The biotech company priced its Hong Kong IPO at $22.6 per share. Details on the deal size, oversubscription ratio, cornerstone investors, and lead underwriters have not yet been disclosed.
The strong first-day pop reflects robust investor appetite for biotech listings on the Hong Kong exchange, a sector that has seen renewed interest after a period of subdued activity. The opening price implies a market valuation well above the IPO level, rewarding early investors who participated in the offering.
The debut performance will test whether institutional demand can sustain the gray market premium in the sessions ahead. Investors will watch for post-IPO price stabilization and any updates on the company's clinical pipeline as the next catalyst for the stock.
This article is for informational purposes only and does not constitute investment advice.
